FAGOTTI, Anna
 Distribuzione geografica
Continente #
NA - Nord America 2.828
EU - Europa 2.627
AS - Asia 1.578
SA - Sud America 525
AF - Africa 30
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 2
Totale 7.596
Nazione #
US - Stati Uniti d'America 2.790
SG - Singapore 818
IE - Irlanda 610
BR - Brasile 457
RU - Federazione Russa 392
SE - Svezia 385
UA - Ucraina 348
IT - Italia 298
VN - Vietnam 219
DE - Germania 209
HK - Hong Kong 205
FI - Finlandia 194
CN - Cina 184
GB - Regno Unito 44
FR - Francia 32
AR - Argentina 31
CH - Svizzera 26
TR - Turchia 25
AT - Austria 18
CA - Canada 17
IN - India 17
PL - Polonia 17
EC - Ecuador 16
UZ - Uzbekistan 16
ID - Indonesia 14
NL - Olanda 12
BD - Bangladesh 11
KR - Corea 11
CZ - Repubblica Ceca 10
MX - Messico 10
PK - Pakistan 10
ES - Italia 9
IQ - Iraq 9
ZA - Sudafrica 9
LB - Libano 7
CL - Cile 6
EU - Europa 6
GR - Grecia 6
JP - Giappone 6
LT - Lituania 6
TN - Tunisia 6
CO - Colombia 5
MA - Marocco 4
SA - Arabia Saudita 4
AZ - Azerbaigian 3
JM - Giamaica 3
KE - Kenya 3
PY - Paraguay 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
BG - Bulgaria 2
DO - Repubblica Dominicana 2
EG - Egitto 2
IL - Israele 2
JO - Giordania 2
NP - Nepal 2
PE - Perù 2
SK - Slovacchia (Repubblica Slovacca) 2
UY - Uruguay 2
VE - Venezuela 2
AF - Afghanistan, Repubblica islamica di 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BY - Bielorussia 1
CG - Congo 1
CR - Costa Rica 1
CY - Cipro 1
DZ - Algeria 1
GA - Gabon 1
GE - Georgia 1
GP - Guadalupe 1
GT - Guatemala 1
HR - Croazia 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MD - Moldavia 1
ME - Montenegro 1
MY - Malesia 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
OM - Oman 1
PH - Filippine 1
PR - Porto Rico 1
SI - Slovenia 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
ZW - Zimbabwe 1
Totale 7.596
Città #
Dublin 610
Chandler 463
Singapore 412
San Mateo 328
Boardman 225
Hong Kong 205
Altamura 174
Santa Clara 172
Medford 167
Princeton 164
Moscow 140
Lawrence 121
Wilmington 116
Andover 113
Dong Ket 113
Ashburn 58
Ho Chi Minh City 51
Saint Petersburg 50
Beijing 35
São Paulo 35
Falls Church 34
Norwalk 27
Ann Arbor 26
New York 24
Los Angeles 21
Munich 21
Cattolica 19
Helsinki 18
San Paolo di Civitate 17
Izmir 16
Columbus 15
Des Moines 15
Hanoi 15
Perugia 15
Rome 15
Nuremberg 13
Hanover 11
Seoul 11
The Dalles 11
Rio de Janeiro 10
Da Nang 9
Den Haag 9
Brasília 8
Turku 8
Boston 7
Caivano 7
Chicago 7
Porto Alegre 7
Belo Horizonte 6
Fortaleza 6
Guayaquil 6
Manaus 6
Manchester 6
Milan 6
Phoenix 6
Shanghai 6
Tokyo 6
Warsaw 6
Baghdad 5
Campinas 5
Caxias do Sul 5
Guarulhos 5
Haiphong 5
Johannesburg 5
Ribeirão Preto 5
Salto 5
Santiago 5
Tappahannock 5
Tashkent 5
Vienna 5
Ankara 4
Bengaluru 4
Biên Hòa 4
Brooklyn 4
Campo Grande 4
Cape Town 4
Charlotte 4
Cotia 4
Council Bluffs 4
Curitiba 4
Dhaka 4
Diadema 4
Fremont 4
Guangzhou 4
Jacksonville 4
Macaé 4
Maceió 4
Montreal 4
Quito 4
Santo André 4
Baku 3
Bauru 3
Camaçari 3
Campos dos Goytacazes 3
Canoas 3
Chongqing 3
Feira de Santana 3
Frankfurt Am Main 3
Goiânia 3
Jakarta 3
Totale 4.398
Nome #
Minimally invasive secondary cytoreduction plus HIPEC for recurrent ovarian cancer: a case series. 91
Laparoendoscopic single-site surgery for fertility-sparing staging of border line ovarian tumors: initial experience. 79
Isterectomia laparoscopica: chirurgica single-port e mini-laparoscopia 79
Advanced ovarian cancer: diagnosis and prediction of optimal cytoreduction 77
Timing and Pattern of Recurrence in Ovarian Cancer Patients with High Tumor Dissemination Treated with Primary Debulking Surgery Versus Neoadjuvant Chemotherapy. 75
Chirurgia nella terapia primaria del carcinoma ovarico 73
Reply to "Let’s Think Twice Before Abandoning Fibrillar Oxidized Regenerated Cellulose" 73
Elderly and very elderly advanced ovarian cancer patients: Does the age influence the surgical management? 72
Cytoreductive surgery plus HIPEC in platinum-sensitive recurrent ovarian cancer patients: A case-control study on survival in patients with two year follow-up. 71
Antiestrogeni e apoptosi 69
Isterectomia laparoscopica semplice e radicale: terminologia, classificazione e tecnica chirurgica. In: Isterectomia laparoscopica. 69
A multi-centric trial to validate the reliability of a laparoscopic score to assess intraperitoneal diffusion of the advanced ovarian cancer 69
Postoperative ileus after para-aortic lymphadenectomy: a prospective study. 68
p53 gene status and response to platinum/paclitaxel-based chemotherapy in advanced ovarian carcinoma. 67
Surgical management of advanced ovarian cancer: a 20-years experience in a tertiary gynecologic oncology unit. 66
Analysis of cyclooxygenase-2 (COX-2) expression in different sites of endometriosis and correlation with clinico-pathological parameters. 65
The sonographic prediction of invasive carcinoma in unilocular-solid ovarian cysts in premenopausal patients: a pilot study. 65
Laparoscopy and ovarian cancer: from diagnosis to recurrence 65
A prospective randomized study of laparoscopy and minilaparotomy in the management of benign adnexal masses. 65
A laparoscopy-based score to predict surgical outcome in patients with advanced ovarian carcinoma: a pilot study. 64
Assessment of pathological status of lower pelvic nodes to tailor surgery in not squamous early cervical carcinoma. 63
Bcl-2, bax, bcl-x(L) and bcl-x(S) expression in neoplastic and normal cervical tissue. 63
Prognostic significance of receptors for epidermal growth factor, estrogen, and progesterone in ovarian cancer. 63
Carcinosi peritoneali 62
Glutathione S-transferase activity in epithelial ovarian cancer: association with response to chemotherapy and disease outcome. 60
Learning curve and pitfalls of a laparoscopic score to describe peritoneal carcinosis in advanced ovarian cancer. 60
Role of CT scan-based and clinical evaluation in the preoperative prediction of optimal cytoreduction in advanced ovarian cancer: a prospective trial. 60
Comparison of peritoneal carcinomatosis scoring methods in predicting resectability and prognosis in advanced ovarian cancer. 59
Advances in surgical management of cervical cancer. 59
Impact of interval debulking surgery on clinical outcome in primary unresectable FIGO stage IIIc ovarian cancer patients. 59
O538 A RANDOMIZED STUDY COMPARING THE USE OF THE LIGACLIP WITH ENSEAL TO PREVENT LYMPHOCELE DURING LAPAROSCOPIC PELVIC LYMPHADENECTOMY FOR GYNECOLOGIC CANCER 59
A randomized study comparing the use of the Ligaclip with bipolar energy to prevent lymphocele during laparoscopic pelvic lymphadenectomy for gynecologic cancer. 58
Pre-hysterectomy cone biopsy is able to predict response in locally advanced cervical cancer patients submitted to neo-adjuvant chemoradiation 58
Ultrasound and color power Doppler in the detection of metastatic omentum: a prospective study. 57
A prospective study of laparoscopy versus minilaparotomy in the treatment of uterine myomas. 57
M487 PLATELET GEL AND VULVAR CARCINOMA: A PILOT STUDY 57
Total laparo-endoscopic single site surgery (less) hysterectomy in low-risk early endometrial cancer: technique and preliminary results 56
Systematic pelvic and aortic lymphadenectomy in advanced ovarian cancer patients at the time of interval debulking surgery: a double-institution case-control study. 56
A multicentric trial (Olympia–MITO 13) on the accuracy of laparoscopy to assess peritoneal spread in ovarian cancer 56
Prospective validation of a laparoscopic predictive model for optimal cytoreduction in advanced ovarian carcinoma. 55
Ultrasound evaluation of intra-abdominal sites of disease to predict likelihood of suboptimal cytoreduction in advanced ovarian cancer: a prospective study. 55
Advanced vulvar carcinoma: is it worth operating? A perioperative management protocol for radical and reconstructive surgery. 54
Preoperative chemoradiotherapy in locally advanced cervical cancer: long-term outcome and complications 53
Simple conization and lymphadenectomy for the conservative treatment of stage IB1 cervical cancer. An Italian experience. 52
A treatment selection protocol for recurrent ovarian cancer patients: the role of FDG-PET/CT and staging laparoscopy. 52
Simple conization and lymphadenectomy for the conservative treatment of stage ib1 cervical cancer 52
Pegylated liposomal doxorubicin-related palmar-plantar erythrodysesthesia ('hand-foot' syndrome). 52
Increased cyclooxygenase-2 expression is associated with better clinical outcome in patients submitted to complete ablation for severe endometriosis. 52
Robotic single-site hysterectomy (RSS-H) vs. laparoendoscopic single-site hysterectomy (LESS-H) in early endometrial cancer: A double-institution case–control study 52
Comparison of optimal cytoreduction rates in emergency versus non-emergency admissions for advanced ovarian cancer: A multi-institutional study 52
Laparoendoscopic single-site surgery for the treatment of benign adnexal disease: a prospective trial. 51
Reply to: Laparoscopy or minilaparotomy as minimally invasive surgical approach for uterine leiomyomas? An unsolved question 51
Robotic treatment of colorectal endometriosis: technique, feasibility and short-term results. 50
La recidiva: diagnosi e indicazioni alla chirurgia secondaria 50
Long-term analysis of clinical outcome and complications in locally advanced cervical cancer patients administered concomitant chemoradiation followed by radical surgery. 50
[Prevention of postoperative abdominal adhesions in gynecological surgery. Consensus paper of an Italian gynecologists' task force on adhesions]. 50
Excisional cone as fertility-sparing treatment in early-stage cervical cancer. 50
Is frozen section analysis of pelvic lymph nodes accurate in locally advanced cervical cancer patients administered preoperative chemoradiation? 50
Preoperative concomitant chemoradiotherapy in locally advanced cervical cancer: safety, outcome, and prognostic measures. 50
Upper abdominal surgery in advanced and recurrent ovarian cancer: role of diaphragmatic surgery. 49
Narrow-Band Imaging in Laparoscopic Management of Recurrent Platinum Sensitive Ovarian Cancer 49
Douglas peritonectomy compared to recto-sigmoid resection in optimally cytoreduced advanced ovarian cancer patients: analysis of morbidity and oncological outcome. 49
Immunoradiometric and immunohistochemical analysis of Cathepsin D in ovarian cancer: lack of association with clinical outcome. 49
GLUT-1 expression in ovarian carcinoma: association with survival and response to chemotherapy 49
Minilaparotomy for type II and III radical hysterectomy: technique, feasibility, and complications. 49
Isterectomia laparoscopica 48
Laparoscopic myomectomy at 25 weeks of pregnancy: case report. 48
Tumori maligni del collo dell’utero 47
Recurrence: diagnosis and indications for secondary surgery 47
Laparoscopic colorectal resection for bowel endometriosis: feasibility, complications, and clinical outcome. 47
Epidermal growth factor, oestrogen and progesterone receptor expression in primary ovarian cancer: correlation with clinical outcome and response to chemotherapy. 47
Il tumore ovarico avanzato: diagnosi e predizione della citoriduzione ottimale 46
Which role for pre-treatment laparoscopic staging? 46
Laparoendoscopic single-site surgery (LESS) for ovarian cyst enucleation: report of first 3 cases. 46
[Biological factors with prognostic significance in ovarian cancer]. 46
Role of pegylated liposomal doxorubicin (PLD) in epithelial ovarian cancer. 45
Laparoscopia e cancro ovarico: dalla diagnosi alla recidiva 45
Narrow band imaging in borderline ovarian tumor. 45
Re: "External validation of a laparoscopic-based score to evaluate resectability of advanced ovarian cancers: clues for a simplified score". 45
Survival after pelvic exenteration for cervical cancer: a retrospective multicentric study of 158 patients 45
Re: "Diagnostic open laparoscopy in the management of advanced ovarian cancer". 44
Laparoscopic diagnosis of asymptomatic megaureter. 44
Radiofrequency bipolar coagulation for radical hysterectomy: technique, feasibility and complications. 44
Nuovi fattori prognostici in ginecologia oncologica 44
LARCIST: a new proposed method for the assessment of response to chemotherapy in advanced ovarian cancer patients 44
Cytoplasmic expression of oestrogen receptor beta (ERβ) as a prognostic factor in vulvar squamous cell carcinoma in elderly women. 44
Morbidity and outcomes after pelvic exenteration for gynecological malignancies: a retrospective multicentric study of 205 patients 44
Severe prolonged gastroparesis after cytoreductive surgery in an advanced ovarian cancer patient. 44
Laparoendoscopic single-site radical hysterectomy with pelvic lymphadenectomy: initial multi-institutional experience for treatment of invasive cervical cancer. 44
Minilaparotomy in early stage endometrial cancer: an alternative to standard and laparoscopic treatment. 43
p21WAF1/CIP1 protein expression in primary ovarian cancer. 43
Indicatori di capacità metastatizzante e prognosi nei tumori ovarici 43
Pelvic disease in primary advanced ovarian cancer: the role of peritonectomy of douglas compared with rectosigmoid resection 43
Diagnosi e trattamento dei tumori del collo dell'utero 43
p53 overexpression is associated with cytoreduction and response to chemotherapy in ovarian cancer. 43
Role of different approaches to the abdominal retroperitoneum for aortic lymphadenectomy in patients with gynecological cancers 42
Totally laparoscopic treatment in early stage endometrial cancer: feasibility, complications and long-term results in a single-institutional series. 42
Standardized training programmes for advanced laparoscopic gynaecological surgery 42
W110 THE SONOGRAPHIC PREDICTION OF INVASIVE CARCINOMA IN UNILOCULAR-SOLID OVARIAN CYSTS IN PREMENOPAUSAL PATIENTS: A PILOT STUDY 42
Reply to: "Some criticism about laparo-endoscopic single-site surgery (LESS) in gynecological surgery for benign and malignant diseases" 41
Totale 5.427
Categoria #
all - tutte 45.536
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.536


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021360 0 0 0 0 0 85 9 0 66 42 24 134
2021/20221.115 21 193 9 52 18 20 13 474 11 6 14 284
2022/20231.929 166 314 0 132 202 179 4 91 775 2 44 20
2023/2024494 56 91 34 7 3 2 107 3 1 14 60 116
2024/20251.322 7 176 6 16 169 6 56 138 352 103 153 140
2025/20261.377 202 196 244 460 199 76 0 0 0 0 0 0
Totale 7.768